Results 31 to 40 of about 3,528 (147)

A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome? [PDF]

Frontiers in Endocrinology, 2022
AimTo determine the efficacy and safety of inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with breast cancer.MethodsIn this multi- institutional cohort study, a total of 160 breast cancer patients (mean age of 50.01 ± 11.5 years old) were ...
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, Babak PeyroShabany, Mohsen Tabasi, Danial Fazilat-Panah, Mahtab Khajeh, Arezoo Mehrabian, Mansoureh Dehghani, James S. Welsh, Batol Keykhosravi, Azam Akbari Yazdi, Mona Ariamanesh, Ahmad Ghasemi, Gordon Ferns, Seyed Alireza Javadinia   +15 more
doaj   +2 more sources

Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine [PDF]

Immunity, Inflammation and Disease, 2022
Inoka Sepali Aberathna, Achala Kamaladasa, Dinuka Guruge   +2 more
exaly   +2 more sources

Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.

PLoS ONE, 2022
The kinetics and magnitude of antibody responses to different proteins of the SARS-CoV-2 virus in Sinopharm/BBIBP-CorV vaccinees has not been previously studied. Therefore, we investigated antibody responses to different SARS-CoV-2 proteins at 2 weeks, 3
Chandima Jeewandara, Inoka Sepali Aberathna, Shashika Dayarathna, Thashmi Nimasha, Thushali Ranasinghe, Jeewantha Jayamali, Achala Kamaladasa, Maneshka Karunanada, Lahiru Perera, Graham S Ogg, Gathsaurie Neelika Malavige   +10 more
doaj   +2 more sources

New-onset systemic lupus erythematosus after BBIBP-CorV vaccination. [PDF]

Clin Case Rep
Key Clinical Message While reports of new‐onset systemic lupus erythematosus (SLE) after mRNA‐based COVID‐19 vaccines exist, no such reports have been documented following inactivated vaccines.
Pourkarim F, Khani E, Ghadakchi L, Ebrahimian S.   +3 more
europepmc   +2 more sources

Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm [PDF]

Iranian Journal of Immunology, 2022
Background: Vaccines are the most effective way to prevent Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2).Objectives: To compare the antibody response of healthy individuals vaccinated with either the AstraZeneca (ChAdOx1 nCoV-19) or the ...
Enayat Anvari, Atefe Talepoor, Mahsa Eshkevar Vakili, Narges Karimi, MohammadReza Ataollahi, Gelareh Najafi, Dieter Kabalitz, Iraj Ahmadi, Kurosh Kalantar   +8 more
doaj   +1 more source

Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.

PLoS ONE, 2022
BackgroundMass vaccination is the key element in controlling current COVID-19 pandemic. Studies comparing immunogenicity of different COVID-19 vaccines are largely lacking. We aimed at measuring anti-S antibody (Ab) levels in individuals fully vaccinated
Vladimir Petrović, Vladimir Vuković, Aleksandra Patić, Miloš Marković, Mioljub Ristić   +4 more
doaj   +1 more source

Ischemic stroke following COVID-19 vaccination [PDF]

Journal of Research in Clinical Medicine, 2023
Following the coronavirus disease 2019 (COVID-19) vaccination, complications are expected. In this regard, coagulopathy after COVID-19 vaccination has been reported.
Nooshin Masoudian, Maryam Kakovan, Samaneh Ghorbani Shirkouhi, Fatemeh Ehsani, Sasan Andalib   +4 more
doaj   +1 more source

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial [PDF]

, 2022
NVSI-06-08 is a potential broad-spectrum recombinant COVID-19 vaccine that integrates the antigens from multiple SARS-CoV-2 strains into a single immunogen.
Cong, Xiangfeng, Liu, Dan Ying, Wang, Zhao Nian, Mao, Xiao Yan, Yang, Xiao Ming, Li, Meng, Eltantawy, Islam, Yin, Jin Liang, Liang, Yu, Yang, Sen Sen, Zhang, Jing, Wang, Zhao, Yin, Jin, ElDein, Mohamed Saif, Lei, Wenwen, Lei, Ze, Tan, Yao, Xu, Ke, Yang, Mengjie, Zhang, Jin, Yang, Yun, Gao, Xue Jun, Mahmoud, Sally, Zhang, Xue, Xiao, Peng, Li, Qi Ming, Li, Qi, Gao, Xue, Hou, Jun, Du, Li, Yang, Tian, Mekki, Hanadi Mekki, Yang, Sen, Yang, Xiao, Du, Li Fang, Mao, Xiao, Zhang, Yun Tao, Jiang, Zhiwei, Qu, Chang, Kang, Yun, Wang, Hui, Kaabi, Nawal Al, Zaher, Walid, Mekki, Hanadi, Shao, Shuai, Liu, Dan, Zhang, Yun, Hussein, Salah, Kaabi, Nawal, Su, Ji, Wu, Guizhen, Yang, Yun Kai, Hou, Jun Wei, Su, Ji Guo, Qu, Liang, Lei, Ze Hua, ElDein, Mohamed   +56 more
core   +1 more source

BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome. [PDF]

Vaccines (Basel), 2023
Several observational studies have confirmed that the severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) might substantially affect the gastrointestinal (GI) system by replicating in human small intestine enterocytes.
Shen Y, Dong Y, Jiao J, Wang P, Chen M, Li J.   +5 more
europepmc   +2 more sources

RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine

BMC Infectious Diseases, 2022
Background Limited information is available on the effectiveness of the BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine, especially in the elderly, despite the fact that it is approved in more than 50 countries.
Tamás Ferenci, Balázs Sarkadi
doaj   +1 more source